Welcome to SociableLabs!

Syn Promo Codes for September 2026

Explore the latest Syn Stock Prices, current deals, and savings on VCN-01 oncolytic adenovirus, SYN-004 ribaxamase. We regularly review available offers, remove expired promotions, and keep this page updated for September 2026.

Syn offers 0 coupon codes and 14 deals as of September 2026. Today's top offer: Investor Briefings on SYN-004 Development. Codes are verified and updated daily.

🔥 Top Syn Discount Codes for September 9, 2026

35%
OFF
Investor Briefings on SYN-004 Development

Access recent investor presentations detailing progress of SYN-004. Information is available for potential investors.

35%
OFF
Insights into Therapeutic Virus Engineering

Explore recent publications on therapeutic virus engineering techniques. This includes advancements in design.

30%
OFF
Expanded Access Program for VCN-01

Information on the expanded access program for VCN-01 is available. Patients with serious conditions may inquire.

15%
OFF
ASCO Meeting Updates on Retinoblastoma Treatment

Find the latest developments presented at the ASCO Annual Meeting. This includes new data on retinoblastoma treatments.

45%
OFF
Fast Track Status for Immuno-Oncology Drug

One immuno-oncology treatment has been granted Fast Track status. This designation accelerates review processes.

20%
OFF
SYN-020 Intestinal Alkaline Phosphatase Research

New research findings on SYN-020 intestinal alkaline phosphatase are available. This relates to gastrointestinal disease treatments.

50%
OFF
Patient Recruitment for Colorectal Cancer Studies

Opportunities exist for patient recruitment in colorectal cancer clinical trials. Specific enrollment criteria apply.

25%
OFF
Orphan Drug Designation for a New Treatment

A new therapeutic candidate has received Orphan Drug Designation. This supports development for rare diseases.

25%
OFF
JP Morgan Conference Investor Relations Summary

Summaries from the JP Morgan Healthcare Conference are posted. Investors can review key takeaways.

45%
OFF
Beta-lactamase Mediated Dysbiosis Prevention Data

Data on beta-lactamase mediated dysbiosis prevention is presented. This covers findings from SYN-004 studies.

40%
OFF
Updates on Pancreatic Cancer Therapy Research

Learn about new research findings in pancreatic cancer treatment. Information is shared through press releases.

45%
OFF
Quarterly Earnings Call Transcript Access

Transcripts from recent quarterly earnings calls are accessible. These provide financial and operational updates.

20%
OFF
Theriva Biologics Annual Report Available

Review the comprehensive annual report for financial insights and company updates. This document covers fiscal year performance.

15%
OFF
Intratumoral Virus Delivery Protocol Updates

Updates regarding intratumoral virus delivery protocols are available. These refine targeted tumor treatments.

Customer Reviews

4.5
Average Rating
2
Total Reviews
Gwen J.
★★★★☆
1 month ago

Good investor info

I checked out their site after hearing about the company. Was mostly interested in their investor presentation. Found it pretty quick, gave a good sense of their immuno-oncology treatments. Not really a shopping site, more for info, but it was easy to get what I needed.

✓ Reply submitted. Will be published after approval.
Minimum 10 characters0 / 2,000
Laura Foster
★★★★★
1 month ago

Clear info on VCN-01 progress

I was looking for an update on the VCN-01 oncolytic adenovirus, specifically its phase 2 data for pancreatic cancer. The website provided a very clear overview of the clinical trial protocols and current status. It was easy to navigate to the relevant sections and find the latest press releases. They didn't have a direct 'shop' for products, which makes sense for a biotech, but the information hub was well-organized for someone following their pipeline. Contacting investor relations was also straightforward for further questions.

✓ Reply submitted. Will be published after approval.
Minimum 10 characters0 / 2,000

Syn Community Discussion

Share tips, ask questions & help fellow shoppers save more

C
Carly
1 month ago

Is there any way to get some kind of discount or financial help for these treatments if I were to participate in a trial?

K Kevin Whitfield 1 month ago
Nah, they're a biotech company, not selling stuff like that. No coupons or anything.
0
S Shane 1 month ago
I don't think they do patient assistance like you'd get for regular meds. Your best bet for 'financial help' is if you qualify for a clinical trial, which usually covers the treatment costs themselves, but not like, a discount code.
3
4 Responses (2)
B
Ben
1 month ago

Hey, wondering if VCN-01 is still in trials? Or is it available for treatment yet?

J Josh Brooks 1 month ago
Still in trials, man. Saw something recently about their Phase 2 data coming out, I think for pancreatic cancer.
3
R Rosa T. 1 month ago
Yeah, definitely not available for general use. They're enrolling patients for studies if you qualify, that's the only way to access it right now.
5
3 Responses (2)

This page may contain affiliate links. If you make a purchase through these links, we may earn a small commission at no extra cost to you. This helps us keep our service free and continue bringing you the best deals.